Early Detection, Better Outcomes: Addressing unmet needs in type 1 diabetes
Event registration will close on 27 October 2025 at 23:59.
campaign
4 November 2025

Early Detection, Better Outcomes: Addressing unmet needs in type 1 diabetes

The event, co-organised by the European Diabetes Forum (EUDF) and EDENT1FI, with support of the Danish Presidency of the Council of the European Union, will address the early diagnosis of type 1 diabetes, ongoing research and innovative approaches to treatment.

Date and time

event
4 November 2025 from 12:00 to 14:00 (Europe/Brussels)

Location

location_on
European Parliament, Brussels
videocam
Online help
not_listed_location
To Be Announced

Refund policy

No refunds will be issued for cancellations

About this event

Join us on November 4 to discuss the early detection and disease-modifying therapies in type 1 diabetes. See below our full programme:


Welcome and opening statement

Welcome and perspective from the European Parliament

  • MEP Stine Bosse, SANT Committee

The importance of a strong life sciences ecosystem

  • Simone Overby Sloth, Counsellor for Health, Permanent Representation of Denmark to the EU


Early Diagnosis of Type 1 diabetes

Introduction to T1D and Early detection for T1D in Europe: EDENT1FI

  • Prof. Dr. Chantal Mathieu, President EASD/EFSD, Vice-Chair EUDF, UZ Leuven

Learnings from Italy: best practice

  • Prof. Dr. Emanuele Bosi, San Raffaele Hospital, Milan


Testimonials and thoughts from people living with T1D 

Moderator: Jurgen Vercauteren, EDENT1FI Patient Advisory Committee

Panel:

  • Maria Hartmann Tørnes and her 13-year-old daughter Cathrine
  • Michaela Mervartová
  • Francesca Ulivi
  • Kirsten Jorsal 
  • MEP Niels Flemming Hansen


Research and early detection as a basis for early intervention and disease interception

Early detection of type 1 diabetes - the Scandinavian perspective

  • Finn Kristensen, Program Director, DiaUnion

Driving European Competitiveness Through Health Research

  • Dr Petra Goyens, Deputy Head of Combatting Diseases Unit, DG RTD EU Commission

IHI's model: how to build bold collaborations and put Europe at the forefront of T1D research

  • Klelia Salpea, Scientific Officer, IHI

EUDF recommendations for clinical implementation of disease modifying therapies

  • Carmen Hurtado del Pozo, Director European Research, Breakthrough T1D


Round table: EUDF recommendations for clinical implementation of disease modifying therapies

Moderator: Prof. Dr. Chantal Mathieu

Panel:

  • Carmen Hurtado del Pozo, Director European Research, Breakthrough T1D
  • Prof. Dr. Pieter Gillard, EASD
  • Dr. Sufyan Hussain, IDF-Europe
  • Luciana Gusukuma, Sanofi
  • Maddy Farnworth, Novo Nordisk 


Conclusion and Call to action 

Call to action

  • MEP Stine Bosse, SANT Committee
  • Prof. Dr. Chantal Mathieu